78 related articles for article (PubMed ID: 19922478)
1. Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin.
Ponte P; Serrão V; Viana I; Vale E; João A; Cerroni L
J Cutan Pathol; 2011 Mar; 38(3):301-5. PubMed ID: 19922478
[TBL] [Abstract][Full Text] [Related]
2. Pagetoid reticulosis with CD30 positivity and cytotoxic/suppressor cells.
Jacyk WK; Grayson W; Dinkel JE; Requena L
J Cutan Pathol; 2007 Aug; 34(8):644-7. PubMed ID: 17640236
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
[TBL] [Abstract][Full Text] [Related]
4. Pathobiology of CD30+ cutaneous T-cell lymphomas.
Kadin ME
J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
[TBL] [Abstract][Full Text] [Related]
5. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
6. CD30(+) cutaneous lymphoma in association with atopic eczema.
Fletcher CL; Orchard GE; Hubbard V; Whittaker SJ; Edelson RL; Russell-Jones R
Arch Dermatol; 2004 Apr; 140(4):449-54. PubMed ID: 15096373
[TBL] [Abstract][Full Text] [Related]
7. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
[TBL] [Abstract][Full Text] [Related]
9. Signet ring cell primary cutaneous CD30+ lymphoproliferative disorder presenting as a monomorphic T-cell posttransplant lymphoproliferative disease.
Papalas JA; Kulbacki EL; Park HK; Howell ER
Am J Dermatopathol; 2012 Oct; 34(7):e94-6. PubMed ID: 22534639
[TBL] [Abstract][Full Text] [Related]
10. Nasal-type extranodal natural killer/T-cell lymphoma presenting with extensive leg ulcers.
Chia HY; Tey HL; Tan KB; Chong WS
Clin Exp Dermatol; 2009 Dec; 34(8):e693-5. PubMed ID: 20055838
[TBL] [Abstract][Full Text] [Related]
11. Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.
Aldaoud A
Dermatol Clin; 2008 Jan; 26 Suppl 1():15-7. PubMed ID: 18405181
[No Abstract] [Full Text] [Related]
12. Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy.
French LE; Shapiro M; Junkins-Hopkins JM; Vittorio CC; Rook AH
J Am Acad Dermatol; 2001 Dec; 45(6):914-8. PubMed ID: 11712039
[TBL] [Abstract][Full Text] [Related]
13. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
Kempf W
J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
15. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
16. Atypical intravascular CD30+ T-cell proliferation following trauma in a healthy 17-year-old male: first reported case of a potential diagnostic pitfall and literature review.
Baum CL; Stone MS; Liu V
J Cutan Pathol; 2009 Mar; 36(3):350-4. PubMed ID: 19220631
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells.
Zhang L; Shao H
J Cutan Pathol; 2013 Aug; 40(8):720-4. PubMed ID: 23672694
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous anaplastic CD30 + large-cell lymphoma that completely regressed after incisional skin biopsy.
Gencoglan G; Ozturk F; Inanir I; Miskioglu M; Temiz P; Gunduz K
Cutan Ocul Toxicol; 2011 Jun; 30(2):163-6. PubMed ID: 21083511
[TBL] [Abstract][Full Text] [Related]
19. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
20. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
Kaudewitz P; Stein H; Dallenbach F; Eckert F; Bieber K; Burg G; Braun-Falco O
Am J Pathol; 1989 Aug; 135(2):359-67. PubMed ID: 2551170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
